High rates of virologic suppression were observed among Black patients who received long-term ART with BIC/FTC/TAF for HIV management.

Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

Explore HIV prevention options for women, including dapivirine rings and dual prevention pills, aiming to reduce infections ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...

7 October 2024 (Lima, Peru) – New data from the PURPOSE 2 study of twice-yearly lenacapavir for HIV prevention are among the scientific highlights at HIVR4P 2024, the 5th HIV Research for Prevention ...

aSection of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA bDepartment of Pathology, Yale School of Medicine, New Haven, CT 06511, USA cDepartment ...

The start of AIDS Awareness Month puts a spotlight on how treatment for HIV and AIDS has progressed over the past 40 years.

He says that three days after receiving the therapy, he felt his skin loosen ... more than a year after receiving the treatment. Researchers have therefore started creating CAR-T therapies from ...

Lenacapavir was approved by the FDA in December 2022 as an HIV treatment. It is given in combination with other antiretrovirals. Treatment begins with an injection and tablets followed by an injection ...

HIV Deaths in the U.S. Today, people living with the virus can enjoy normal to near-normal life expectancy even in countries where infection rates are high. This article takes a closer look at how ...